-
Trafalgar Asset Management acquires voting control of Greater Cannabis Company, appoints new CEO
Trafalgar Asset Management purchased 100% of Series A and Series B preferred stock, gaining 96.62% voting power as of June 29, 2026.
-
GCAN files Series B Preferred Stock giving CEO Aitan Zacharin 51% voting control
Created 1,000 Series B Convertible Preferred Shares with 51% total voting power.
-
Greater Cannabis implements 1-for-1,500 reverse stock split effective Oct 15, 2025
Outstanding shares reduced from 1,349,888,436 to approximately 900,256.
-
GCAN issues 100M shares to CEO for $10K deferred salary
CEO Aitan Zacharin received 100,000,000 restricted shares on April 3, 2025.
-
GCAN replaces independent auditor Fruci with Olayinka Oyebola & Co effective Jan 25, 2023
Ended engagement of Fruci & Associates II, PLLC as independent auditor on January 25, 2023, approved by board.
-
GCAN extends note maturities to April 2023, obtains default waiver from FFG
Extended maturity of two Convertible Promissory Notes (each $272,500 principal) to April 30, 2023.
-
GCAN signs licensing/research deal with Shaare Zedek for cannabinoid therapy targeting neuropsychiatric disorders
Licensing covers novel cannabinoid therapeutic for autism, schizophrenia, Parkinson's, Alzheimer's, and other neuropsychiatric disorders.